ctx
Showing 1 - 10 of 10
Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma Trial in Suzhou (Selinexor, Flu, CTX)
Recruiting
- Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
- Selinexor
- +3 more
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Apr 3, 2022
Acute Lymphocytic Leukemia, Adult Lymphoblastic Lymphoma Trial in United States (DNR, VCR, PEG-asp)
Terminated
- Acute Lymphocytic Leukemia
- Adult Lymphoblastic Lymphoma
- DNR
- +12 more
-
La Jolla, California
- +3 more
Apr 26, 2022
Triple-negative Breast Cancer Trial in Shanghai (Epirubicin, CTX, Paclitaxel)
Recruiting
- Triple-negative Breast Cancer
- Epirubicin
- +6 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Mar 3, 2020
Hematopoietic Stem Cell Transplantation Trial in China (ATG, CTX, Mycophenolate Mofetil)
Unknown status
- Hematopoietic Stem Cell Transplantation
- ATG
- +4 more
-
Guangzhou, Guangdong, China
- +6 more
Oct 24, 2019
Early Breast Cancer Trial in Shanghai (PLD, CTX, Docetaxel)
Unknown status
- Early Breast Cancer
- PLD
- +4 more
-
Shanghai, ChinaFudan University affiliated cancer hospital
May 13, 2019
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Trial in Nanjing (DFPP&CTX, CTX)
Terminated
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
- DFPP&CTX
- CTX
-
Nanjing, Jiangsu, ChinaResearch Institute of Nephrology, Jinling Hospital, Nanjing Univ
Feb 2, 2018
Multiple Myeloma Trial in Beijing (rhTPO, CTX, -CSF)
Unknown status
- Multiple Myeloma
- rhTPO
- +2 more
-
Beijing, Beijing, ChinaBeijing Chaoyang Hospital
Feb 8, 2017
Breast Cancer Model, Effects of Chemo, Breast Cancer Trial in Guangzhou (NVB, EPI, DDP)
Recruiting
- Breast Cancer Model
- +2 more
- NVB
- +7 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University
Jan 13, 2017